The 9 Best Continuous Glucose Monitors of 2026: Tested & Reviewed

Continuous glucose monitors have transformed diabetes care - and in 2026, the technology has expanded well beyond insulin users to wellness consumers and metabolic health enthusiasts. Where older devices required multiple daily fingersticks for calibration, today's best CGMs like the Dexcom G7 are factory calibrated, feature sub-hour warmup times, and stream glucose data directly to Apple Watch without a phone nearby ^[1]. Whether you're a type 1 diabetic managing a closed-loop insulin pump, a type 2 patient on oral medications, or an athlete tracking metabolic glucose response to meals, there is now a CGM designed for your exact needs and budget ^[3].

We evaluated nine CGM systems across accuracy (MARD percentage), sensor wear duration, warmup time, smartphone and smartwatch compatibility, insurance and Medicare coverage, and out-of-pocket cost ^[3]. Two FDA-cleared over-the-counter CGMs - requiring no prescription whatsoever - now open real-time glucose monitoring to millions of non-insulin users who previously had no clinical pathway to CGM technology ^[5]. Our ranked picks cover every use case from the tightest type 1 control to first-time metabolic tracking, with essential accessories that extend the life and reliability of each sensor ^[4].

The Dexcom G7 achieved a Mean Absolute Relative Difference (MARD) of 8.2% in its FDA pivotal trial - confirming class-leading real-world accuracy among all commercially available CGMs ^[1]. Its 30-minute warmup is unmatched: nearly twice as fast as Abbott's 60-minute Libre sensors and hours ahead of Medtronic's platform. The G7 is FDA-cleared for insulin dosing decisions without a confirmatory fingerstick, making it the most clinically validated choice for type 1 diabetics and those on intensive insulin regimens ^[5]. With good commercial insurance, monthly sensor costs drop to $35–$70; without coverage, the list price runs $300–$400/month, making insurance verification a critical first step ^[8].

The Stelo Glucose Biosensor launched as the first FDA-cleared OTC CGM and has rapidly become the go-to choice for non-insulin type 2 diabetics, prediabetes patients, athletes, and wellness consumers monitoring metabolic response to food and exercise ^[5]. At $99/month for two 15-day sensors, Stelo eliminates the barrier of a physician visit while delivering Dexcom-class accuracy accessible at retail ^[3]. The Stelo app intentionally omits urgent low glucose alarms - its indicated non-insulin population has no need for them - but provides robust pattern analysis, meal-glucose correlations, and activity-based trend insights that most prescription CGM apps do not offer ^[4].

The Abbott FreeStyle Libre 3 Plus is the world's smallest and thinnest CGM sensor, delivering real-time 1-minute glucose readings over a 15-day wear period - 50% longer than the Dexcom G7 and at a meaningfully lower list price of $75–$150/month without insurance ^[2]. To reliably hit the full 15-day wear window, many active users reinforce adhesion with sensor covers like the RHYZIA Freestyle Libre 3/Libre 3 Plus Sensor Covers, which use a non-adhesive center to avoid interfering with the optical sensor dome while securing the surrounding perimeter ^[3]. The Libre 3 Plus is FDA-cleared for type 1 and type 2 diabetes and carries broad Medicare and commercial insurance coverage, often becoming the most affordable prescription CGM after applying GoodRx discounts or Abbott's Libre savings programs.

The Abbott FreeStyle Libre 2 Plus is the most accessible prescription CGM on the market, featuring optional real-time customizable alarms and 15-day sensor wear at just $60–$120/month without insurance - often lower still with GoodRx ^[6]. It maintains broader smartphone compatibility than the newer Libre 3 Plus, supporting a wider range of older Android and iOS devices that may not run the Libre 3 Plus app. Waterproof sensor covers like the 100Pcs Libre 2 Plus Sensor Covers are especially popular with Libre 2 Plus users, preventing early adhesive failure that prematurely ends the 15-day wear period during workouts or water activities ^[3]. Medicare covers the FreeStyle Libre 2 Plus as durable medical equipment for insulin-treated diabetes, making it one of the top CGM choices for senior beneficiaries ^[6].

Medtronic offers two CGM platforms in 2026: the Simplera Sync - a fully disposable 7-day sensor requiring no overtape, designed exclusively for the MiniMed 780G closed-loop system - and the Guardian 4, a 7-day factory-calibrated sensor for MiniMed 670G and 770G users ^[4]. Both systems deliver among the tightest insulin pump integration of any CGM, enabling fully automated basal-rate adjustments that no third-party CGM can match on Medtronic hardware. Active Medtronic users frequently rely on reinforcement patches like OK TAPE Adhesive Patches to extend 7-day adhesion through workouts and showers, particularly relevant given Medtronic sensors' shorter wear window compared to Dexcom and Abbott alternatives ^[3].

The Senseonics Eversense E3 is the only CGM in the world with a 365-day implanted sensor, inserted subcutaneously in a brief in-office procedure and replaced just once per year ^[7]. For patients who find weekly or bi-weekly sensor changes burdensome - particularly those with needle anxiety or adhesive skin reactions - the annual implant eliminates daily adhesive management entirely. Total cost is approximately $3,000–$5,000/year for the implant procedure plus a reusable wearable transmitter (~$300), which compares favorably when annualized against prescription CGM monthly subscription costs ^[7]. The transmitter is worn externally over the implant site, removed and charged nightly, and the system uniquely requires twice-daily fingerstick calibrations - currently the only modern CGM that does, which some users find limiting ^[8].

Abbott Lingo is a 14-day OTC CGM sensor paired with a wellness coaching app designed not for diabetes management but for diet optimization, exercise performance, and metabolic health awareness among non-diabetic users ^[3]. Priced at $49–$89 per sensor OTC with no prescription required, Lingo targets wellness consumers, athletes, and prediabetes individuals who want real-time glucose feedback without a clinical diagnosis ^[4]. Like Stelo, it is not indicated for insulin dosing decisions, but it differentiates itself through personalized metabolic coaching insights - including meal scoring, sleep-glucose correlations, and exercise impact analysis - layered directly on top of glucose trend data.

The Dexcom ONE+ uses the same proven G7 sensor hardware at a lower price point of $200–$280/month without insurance, but offers fewer advanced software features than the full G7 app experience ^[1]. It is available in more countries than the G7 and makes Dexcom's class-leading accuracy accessible in markets where the G7 has not yet achieved reimbursement. For users who primarily need reliable glucose data without advanced data-sharing, smartwatch integration, or third-party closed-loop compatibility, the ONE+ represents an excellent accuracy-to-cost value that should not be overlooked ^[4].